{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:37:46Z","timestamp":1768811866493,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of National Statistical Science Foundation of China","award":["2021LD01"],"award-info":[{"award-number":["2021LD01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71251-3","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:03:56Z","timestamp":1726761836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A mathematical insight to control the disease psoriasis using mesenchymal stem cell transplantation with a biologic inhibitor"],"prefix":"10.1038","volume":"14","author":[{"given":"Subhankar","family":"Kushary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianbing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priti Kumar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"71251_CR1","volume-title":"Global Report on Psoriasis","author":"IM Michalek","year":"2016","unstructured":"Michalek, I. M., Loring, B. & John, S. M. Global Report on Psoriasis (World Health Organization, 2016)."},{"key":"71251_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1142\/S0218339020500084","volume":"28","author":"PK Roy","year":"2020","unstructured":"Roy, P. K., Roy, A. K., Khailov, E. N., Al Basir, F. & Grigorieva, E. V. A model of the optimal immunotherapy of psoriasis by introducing il-10 and il-22 inhibitors. J. Biol. Syst. 28, 609\u2013639 (2020).","journal-title":"J. Biol. Syst."},{"key":"71251_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/bjd.19169","volume":"184","author":"I Iskandar","year":"2021","unstructured":"Iskandar, I., Parisi, R., Griffiths, C., Ashcroft, D. & Atlas, G. P. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br. J. Dermatol. 184, 243\u2013258 (2021).","journal-title":"Br. J. Dermatol."},{"key":"71251_CR4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","volume":"58","author":"A Menter","year":"2008","unstructured":"Menter, A. et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J. Am. Acad. Dermatol. 58, 826\u2013850 (2008).","journal-title":"J. Am. Acad. Dermatol."},{"key":"71251_CR5","unstructured":"Britannica, T. Editors of encyclopaedia. Argon. Encycl. Britannica (2020)."},{"key":"71251_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.643125","volume":"9","author":"\u00c1 Sierra-S\u00e1nchez","year":"2021","unstructured":"Sierra-S\u00e1nchez, \u00c1., Montero-Vilchez, T., Qui\u00f1ones-Vico, M. I., Sanchez-Diaz, M. & Arias-Santiago, S. Current advanced therapies based on human mesenchymal stem cells for skin diseases. Front. Cell Dev. Biol. 9, 643125 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"71251_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","volume":"21","author":"CJ Bashor","year":"2022","unstructured":"Bashor, C. J., Hilton, I. B., Bandukwala, H., Smith, D. M. & Veiseh, O. Engineering the next generation of cell-based therapeutics. Nat. Rev. Drug Discov. 21, 655\u2013675 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"71251_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00011-019-01238-8","volume":"68","author":"C Cataldi","year":"2019","unstructured":"Cataldi, C. et al. Proinflammatory and anti-inflammatory cytokine profiles in psoriasis: Use as laboratory biomarkers and disease predictors. Inflamm. Res. 68, 557\u2013567 (2019).","journal-title":"Inflamm. Res."},{"key":"71251_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-2427(02)00136-8","volume":"88","author":"A Gr\u00f6ne","year":"2002","unstructured":"Gr\u00f6ne, A. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88, 1\u201312 (2002).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"71251_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.smim.2016.03.012","volume":"27","author":"S Puhr","year":"2015","unstructured":"Puhr, S., Lee, J., Zvezdova, E., Zhou, Y. J. & Liu, K. Dendritic cell development\u2014History, advances, and open questions. Semin. Immunol. 27, 388\u2013396 (2015).","journal-title":"Semin. Immunol."},{"key":"71251_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-022-01059-y","volume":"7","author":"L Cheng","year":"2022","unstructured":"Cheng, L. et al. Human umbilical cord mesenchymal stem cells for psoriasis: A phase 1\/2a, single-arm study. Signal Transduct. Target. Ther. 7, 263 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"71251_CR12","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150025","volume":"35","author":"I Ullah","year":"2015","unstructured":"Ullah, I., Subbarao, R. B. & Rho, G. J. Human mesenchymal stem cells-current trends and future prospective. Biosci. Rep. 35, e00191 (2015).","journal-title":"Biosci. Rep."},{"key":"71251_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cytogfr.2007.10.004","volume":"19","author":"P Blanco","year":"2008","unstructured":"Blanco, P., Palucka, A. K., Pascual, V. & Banchereau, J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 19, 41\u201352 (2008).","journal-title":"Cytokine Growth Factor Rev."},{"key":"71251_CR14","volume":"2010","author":"M Xu","year":"2010","unstructured":"Xu, M. et al. Regulation of antitumor immune responses by the il-12 family cytokines, il-12, il-23, and il-27. Clin. Dev. Immunol. 2010, 832454 (2010).","journal-title":"Clin. Dev. Immunol."},{"key":"71251_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-4632.2011.05154.x","volume":"51","author":"S Coimbra","year":"2012","unstructured":"Coimbra, S., Figueiredo, A., Castro, E., Rocha-Pereira, P. & Santos-Silva, A. The roles of cells and cytokines in the pathogenesis of psoriasis. Int. J. Dermatol. 51, 389\u2013398 (2012).","journal-title":"Int. J. Dermatol."},{"key":"71251_CR16","first-page":"365","volume":"42","author":"A Datta","year":"2013","unstructured":"Datta, A. & Roy, P. K. T-cell proliferation on immunopathogenic mechanism of psoriasis: A control based theoretical approach. Control. Cybern. 42, 365\u2013386 (2013).","journal-title":"Control. Cybern."},{"key":"71251_CR17","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes, J. E., Yan, B. Y., Chan, T. C. & Krueger, J. G. Discovery of the il-23\/il-17 signaling pathway and the treatment of psoriasis. J. Immunol. 201, 1605\u20131613 (2018).","journal-title":"J. Immunol."},{"key":"71251_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jtbi.2019.04.007","volume":"474","author":"AK Roy","year":"2019","unstructured":"Roy, A. K., Al Basir, F. & Roy, P. K. A vivid cytokines interaction model on psoriasis with the effect of impulse biologic (tnf- $$\\alpha$$ inhibitor) therapy. J. Theor. Biol. 474, 63\u201377 (2019).","journal-title":"J. Theor. Biol."},{"key":"71251_CR19","first-page":"513","volume":"27","author":"AK Roy","year":"2022","unstructured":"Roy, A. K., Al Basir, F., Roy, P. K. & Chatterjee, A. N. A model analysis to measure the adherence of etanercept and fezakinumab therapy for the treatment of psoriasis. Nonlinear Anal. Model. Control 27, 513\u2013533 (2022).","journal-title":"Nonlinear Anal. Model. Control"},{"key":"71251_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/bjd.20517","volume":"185","author":"S Lwin","year":"2021","unstructured":"Lwin, S., Snowden, J. & Griffiths, C. The promise and challenges of cell therapy for psoriasis. Br. J. Dermatol. 185, 887\u2013898 (2021).","journal-title":"Br. J. Dermatol."},{"key":"71251_CR21","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.3390\/ijms18102182","volume":"18","author":"A Owczarczyk-Saczonek","year":"2017","unstructured":"Owczarczyk-Saczonek, A. et al. Stem cells as potential candidates for psoriasis cell-replacement therapy. Int. J. Mol. Sci. 18, 2182 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"71251_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1172\/JCI1476","volume":"101","author":"K Asadullah","year":"1998","unstructured":"Asadullah, K. et al. Il-10 is a key cytokine in psoriasis. Proof of principle by il-10 therapy: A new therapeutic approach. J. Clin. Investig. 101, 783\u2013794 (1998).","journal-title":"J. Clin. Investig."},{"key":"71251_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12015-011-9311-1","volume":"8","author":"EJ Bassi","year":"2012","unstructured":"Bassi, E. J., de Almeida, D. C., Moraes-Vieira, P. M. M. & C\u00e2mara, N. O. S. Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells. Stem Cell Rev. Rep. 8, 329\u2013342 (2012).","journal-title":"Stem Cell Rev. Rep."},{"key":"71251_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/PTT.S108311","volume":"7","author":"A Campanati","year":"2017","unstructured":"Campanati, A. et al. Role of mesenchymal stem cells in the pathogenesis of psoriasis: Current perspectives. Psoriasis Targets Ther. 7, 73\u201385 (2017).","journal-title":"Psoriasis Targets Ther."},{"key":"71251_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/ijms18020244","volume":"18","author":"T-H Shin","year":"2017","unstructured":"Shin, T.-H., Kim, H.-S., Choi, S. W. & Kang, K.-S. Mesenchymal stem cell therapy for inflammatory skin diseases: Clinical potential and mode of action. Int. J. Mol. Sci. 18, 244 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"71251_CR26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","volume":"9","author":"C Albanesi","year":"2018","unstructured":"Albanesi, C., Madonna, S., Gisondi, P. & Girolomoni, G. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis. Front. Immunol. 9, 1549 (2018).","journal-title":"Front. Immunol."},{"key":"71251_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cellimm.2017.07.010","volume":"326","author":"L Lin","year":"2018","unstructured":"Lin, L. & Du, L. The role of secreted factors in stem cells-mediated immune regulation. Cell Immunol. 326, 24\u201332 (2018).","journal-title":"Cell Immunol."},{"key":"71251_CR28","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/cells8080886","volume":"8","author":"Y Han","year":"2019","unstructured":"Han, Y. et al. Mesenchymal stem cells for regenerative medicine. Cells 8, 886 (2019).","journal-title":"Cells"},{"key":"71251_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/jir.2021.0146","volume":"42","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Yan, J., Li, Z., Zheng, J. & Sun, Q. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate psoriasis-like skin inflammation. J. Interferon Cytokine Res. 42, 8\u201318 (2022).","journal-title":"J. Interferon Cytokine Res."},{"key":"71251_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger, M. F. et al. Mesenchymal stem cell perspective: Cell biology to clinical progress. NPJ Regen. Med. 4, 22 (2019).","journal-title":"NPJ Regen. Med."},{"key":"71251_CR31","first-page":"717","volume":"15","author":"AK Roy","year":"2017","unstructured":"Roy, A. K., Roy, P. K. & Grigorieva, E. Mathematical insights on psoriasis regulation: Role of th1 and th2 cells. Math. Biosci. Eng. 15, 717\u2013738 (2017).","journal-title":"Math. Biosci. Eng."},{"key":"71251_CR32","doi-asserted-by":"publisher","first-page":"13403","DOI":"10.1002\/mma.7635","volume":"44","author":"AK Roy","year":"2021","unstructured":"Roy, A. K., Nelson, M. & Roy, P. K. A control-based mathematical study on psoriasis dynamics with special emphasis on il- 21 and ifn- $$\\gamma$$ interaction network. Math. Methods Appl. Sci. 44, 13403\u201313420 (2021).","journal-title":"Math. Methods Appl. Sci."},{"key":"71251_CR33","doi-asserted-by":"publisher","first-page":"20141071","DOI":"10.1098\/rsif.2014.1071","volume":"12","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Modelling epidermis homoeostasis and psoriasis pathogenesis. J. R. Soc. Interface 12, 20141071 (2015).","journal-title":"J. R. Soc. Interface"},{"key":"71251_CR34","first-page":"551","volume":"24","author":"M Nagumo","year":"1942","unstructured":"Nagumo, M. \u00dcber die lage der integralkurven gew\u00f6hnlicher differentialgleichungen. Proc. Phys. Math. Soc. Jpn. 3rd Ser. 24, 551\u2013559 (1942).","journal-title":"Proc. Phys. Math. Soc. Jpn. 3rd Ser."},{"key":"71251_CR35","volume-title":"Ordinary Differential Equation","author":"G Birkhoff","year":"1982","unstructured":"Birkhoff, G. & Rota, G. Ordinary Differential Equation (Ginn and Co, 1982)."},{"key":"71251_CR36","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1103\/PhysRevA.35.5288","volume":"35","author":"EX DeJesus","year":"1987","unstructured":"DeJesus, E. X. & Kaufman, C. Routh-hurwitz criterion in the examination of eigenvalues of a system of nonlinear ordinary differential equations. Phys. Rev. A 35, 5288 (1987).","journal-title":"Phys. Rev. A"},{"key":"71251_CR37","volume-title":"An Application of Geometric Methods","author":"H Sch\u00e4ttler","year":"2015","unstructured":"Sch\u00e4ttler, H. & Ledzewicz, U. Optimal control for mathematical models of cancer therapies. In An Application of Geometric Methods (eds Sch\u00e4ttler, H. & Ledzewicz, U.) (Springer, 2015)."},{"key":"71251_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.apm.2022.05.038","volume":"110","author":"JG Otero","year":"2022","unstructured":"Otero, J. G., Alcami, A.A.-A. & Belmonte-Beitia, J. Dynamics and analysis of a mathematical model of neuroblastoma treated with celyvir. Appl. Math. Model. 110, 131\u2013148 (2022).","journal-title":"Appl. Math. Model."},{"key":"71251_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00063030-200519010-00006","volume":"19","author":"A-M Tobin","year":"2005","unstructured":"Tobin, A.-M. & Kirby, B. Tnf$$\\alpha$$ inhibitors in the treatment of psoriasis and psoriatic arthritis. BioDrugs 19, 47\u201357 (2005).","journal-title":"BioDrugs"},{"key":"71251_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/00401706.1999.10485594","volume":"41","author":"A Saltelli","year":"1999","unstructured":"Saltelli, A., Tarantola, S. & Chan, K.-S. A quantitative model-independent method for global sensitivity analysis of model output. Technometrics 41, 39\u201356 (1999).","journal-title":"Technometrics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71251-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:09:10Z","timestamp":1726762150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71251-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71251"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71251-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21897"}}